Sartorius Stedim Biotech S.A. (EPA:DIM)
211.80
-3.20 (-1.49%)
Oct 19, 2026, 5:35 PM CET
Sartorius Stedim Biotech Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Maintains €260.00 | Buy | Maintains | €260.00 | +22.76% | Oct 15, 2026 |
| RBC Capital | RBC Capital | Buy Maintains €210.00 | Buy | Maintains | €210.00 | -0.85% | Oct 6, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains €208.00 → €223.00 | Buy | Maintains | €208.00 → €223.00 | +5.29% | Oct 1, 2026 |
| Barclays | Barclays | Buy Maintains €240.00 → €250.00 | Buy | Maintains | €240.00 → €250.00 | +18.04% | Sep 30, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains €260.00 | Buy | Maintains | €260.00 | +22.76% | Sep 28, 2026 |
| Bernstein | Bernstein | Buy Maintains €245.00 → €230.00 | Buy | Maintains | €245.00 → €230.00 | +8.59% | Jul 28, 2026 |
| HSBC | HSBC | Buy Maintains €233.00 → €230.00 | Buy | Maintains | €233.00 → €230.00 | +8.59% | Jun 3, 2026 |